Nov 2022 - SGLT2 Inhibition by Dapagliflozin Mitigates Peritoneal Fibrosis & Ultrafiltration Failure
Channel: ISPD International Society for Peritoneal Dialysis
Date: 2023-01-13

This video corresponds to the recording of the Central Time NAC-JC of November 2022 - SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate